Name:
Dr Isabela Pedroza-Pacheco

Post-nominal Letters:
PhD

Job Title:
Principal Investigator, Immunology & immuno‑oncology

Organisation / Company:
Oxford cancer/immunology research centres

Biography:
Dr. Isabela Pedroza-Pacheco is a Group Leader at the Nuffield Department of Medicine, University of Oxford, where she leads the Laboratory for Functional Immunology. Her research focuses on understanding the cellular and molecular mechanisms underlying the regulation of secondary and tertiary lymphoid structures in vaccination, infection, and cancer, with the goal of identifying mechanistic targets that could be exploited to improve vaccines and therapeutics. Dr. Pedroza completed her PhD in Immunology at University College London and subse-quently undertook postdoctoral training at the University of Oxford under the mentorship of Prof. Andrew McMichael and Prof. Seph Borrow. She has made significant contributions to the fields of HIV and cancer immunology as a faculty member of consortiums at the National Institutes of Health (NIH) in the USA and the Combined Molecular Analysis of Blood and Tissue (COMBAT) in Cancer at Oxford, where she applies advanced technologies, including AI-driven immunology approaches, to disease research.

Since 2023, Dr. Pedroza has served as the programme director of the Oxford Cancer Mexico Initiative, a strategic collaborative alliance between the University of Oxford, the National Polytechnic Institute (IPN) in Mexico, and the General Hospital of Mexico. This initiative aims to establish a cross-institutional network between UK and Mexican scientists to accelerate translational cancer research and improve global health outcomes, with a focus on prevention, diagnosis, and treatment. In recognition of her contributions, Dr. Pedroza was awarded the “Young Faculty Award” by the Consortia for HIV/AIDS Vaccine Development in 2022 and a Research Fellow by Oriel College in 2026.